# FDA Inspection 709134 - Reprotech, Inc - February 10, 2011

Source: https://www.keypedia.com/records/fda_inspections/reprotech-inc/b1a46db3-ae2e-4c0c-8292-e2e8e3725710
Source feed: FDA_Inspections

> FDA Inspection 709134 for Reprotech, Inc on February 10, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 709134
- Company Name: Reprotech, Inc
- Inspection Date: 2011-02-10
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 981452 - 2016-08-23](https://www.keypedia.com/records/fda_inspections/reprotech-inc/63b027b5-fc92-433c-86df-66f2f2fd0f9c)
- [FDA Inspection 835423 - 2013-06-11](https://www.keypedia.com/records/fda_inspections/reprotech-inc/7894467b-492e-4fd8-a5a5-4dfe5509445b)

Company: https://www.keypedia.com/companies/reprotech-inc/4ac2b631-3009-4b7b-9487-cea1661a8446

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d